Viewing Study NCT03096834

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:26 AM
Ignite Modification Date: 2026-05-30 @ 1:20 AM
Study NCT ID: NCT03096834
Status: COMPLETED
Last Update Posted: 2022-03-23
First Post: 2017-03-17
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study Evaluating the Effectiveness of AMG 334 Injection in Preventing Migraines in Adults Having Failed Other Therapies
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Episodic Migraine View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Migraine View
None attack View
None headache View
None episodic View
None aura View
None AMG 334 View
None CGRP receptor agonist View
None erenumab View
None adult View